From uric acid to tophi: multistage molecular and cellular mechanisms of tophi formation - Scorecard - MDSpire

From uric acid to tophi: multistage molecular and cellular mechanisms of tophi formation

  • By

  • Heguo Yan

  • Bo Yang

  • Niqin Xiao

  • Jian Zhang

  • Yundong Xu

  • Bingbing Chen

  • Sanjin Zeng

  • He Qian

  • Shengyi Zhao

  • Rong Wang

  • Jing Xie

  • Zhaofu Li

  • Zhaohu Xie

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Molecular and Cellular Pathways Leading to Tophi Development from Uric Acid Accumulation

At a Glance

CategoryDetail
Condition
Key MechanismsMonosodium urate (MSU) crystal deposition, inflammation, tissue fibrosis
Target PopulationIndividuals with chronic gout, particularly those with prolonged disease duration
Care SettingOutpatient and inpatient settings for chronic gout management

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

    • Assess serum uric acid levels and clinical presentation of gout.

    Management

    • Focus on managing hyperuricemia and associated symptoms.

    Monitoring & Follow-up

    • Regularly monitor uric acid levels and assess for tophi development.

    Risks

    • Increased risk of joint deformities, functional impairment, and renal damage.

    Patient & Prescribing Data

    Patients with chronic gout, especially those with a disease duration exceeding ten years.

    Management strategies should consider the complex pathophysiology of tophus formation.

    Clinical Best Practices

      Related Resources & Content

      Original Source(s)

      Related Content